utilizing actionable classifications in tnbc
Published 4 years ago • 36 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
8:08
histologic subtyping in tnbc
-
2:29
swog s9313: classification of tnbc by dna damage response homologous recombination deficiency
-
5:58
other promising targets in tnbc
-
2:26
a background on tnbc and management
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy
-
6:20
antibody-drug conjugates for tnbc
-
6:30
case study: treating metastatic triple-negative breast cancer
-
6:07
personalized medicine in triple-negative breast cancer
-
6:01
immunotherapy for triple-negative breast cancer
-
4:17
treatment options in metastatic tnbc
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
8:05
key trials in r/r metastatic tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
21:00
precision medicine in metastatic triple negative breast cancer
-
0:36
why don't we know more about triple negative breast cancer? #breastcancer
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc
-
4:38
oncologist explains the challenges of triple-negative breast cancer
-
1:56
dr. schmid on benefit of pembrolizumab in patients with tnbc
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology